-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Hangzhou Dejin Medical Technology Co.
, Ltd.
(hereinafter referred to as "Dejin Medical" and the "Company"), a subsidiary of De Nuo Medical Group ("De Nuo Medical"), announced that it has recently completed Series B financing
.
The financing amounted to hundreds of millions of dollars, and the funds will be mainly used for the company's technological innovation and product development in the treatment of mitral and tricuspid valve diseases
De Nuo Medical is a professional innovative life technology industry investment and operation management enterprise group.
Through the discovery, investment and integration of medical projects with disruptive innovative technologies, it is committed to seeking for major diseases that seriously threaten human health but still lack effective treatments.
The solution
.
Dejin Medical was established in 2015, focusing on the research and development of related treatment technologies for mitral and tricuspid valves
.
Mitral valve regurgitation is the most common disease in heart valve disease.